- The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call
- Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute
- The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California
- The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
- MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
- The Oncology Institute Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call
- The Oncology Institute to Participate at Upcoming Investor Conferences
- Carrum Health and The Oncology Institute Partner on Breast Cancer Treatment Model
- WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio
- The Oncology Institute Expands its Specialty Medication Business by Opening Pharmacy Operations in California
More ▼
Key statistics
On Wednesday, Oncology Institute Inc (TOI:NAQ) closed at 1.12, 239.39% above the 52 week low of 0.33 set on Jun 05, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.07 |
---|---|
High | 1.23 |
Low | 1.07 |
Bid | 0.4503 |
Offer | 1.13 |
Previous close | 1.12 |
Average volume | 67.24k |
---|---|
Shares outstanding | 74.31m |
Free float | 50.83m |
P/E (TTM) | -- |
Market cap | 83.23m USD |
EPS (TTM) | -0.9187 USD |
Data delayed at least 15 minutes, as of May 01 2024 21:00 BST.
More ▼